TERN
- Terns Pharmaceuticals, Inc.
()
Overview
Company Summary
Terns Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing innovative therapeutics for liver diseases. The company's primary goal is to address the significant unmet medical needs in this specific therapeutic area.
Terns Pharma combines expertise in drug discovery, preclinical research, clinical development, and commercialization to develop potential treatments for serious liver conditions. They primarily focus on non-alcoholic steatohepatitis (NASH), a progressive liver disease caused by excessive fat accumulation in the liver, leading to inflammation and fibrosis.
Using their deep understanding of the underlying mechanisms of liver diseases, Terns Pharma identifies promising targets and molecules to address various stages of disease progression. They employ a multidisciplinary approach, utilizing cutting-edge scientific techniques and collaborating with renowned academic institutions, to advance their drug development programs.
Terns Pharmaceuticals aims to develop therapies that will not only halt disease progression but also reverse liver damage and improve patient outcomes. By targeting the root causes and pathology of liver diseases, the company aims to improve the quality of life for patients suffering from NASH and other liver-related disorders.
In summary, Terns Pharmaceuticals is a biopharmaceutical company working diligently to discover, develop, and commercialize innovative therapeutics to combat liver diseases, with a primary focus on NASH.